Navigation Links
Highmark's Collaboration With Hospitals and Doctors Continues to Yield Benefits for all Patients
Date:11/3/2010

PITTSBURGH, Nov. 3, 2010 /PRNewswire/ -- Whether it's reducing infections for patients, increasing the number of generic drugs to reduce costs or collaborating with hospitals to develop a philosophy and culture of quality, Highmark's QualityBLUE pay-for-performance (P4P) programs continue to evolve to help save lives and health care dollars.

The company's most recent internal report on the hospital and physician P4P program demonstrates a number of positive results.

One of the most successful methods found to reduce health care costs is to increase the rate of clinically appropriate generic drug use substitution. Since 2006, when the measure was implemented, the percent of generic medications prescribed has increased from an average of 46 percent to 73 percent. Using the average Highmark prices for generic and brand medications and calculating what would have been paid if QualityBLUE participating physician practices prescribed brand drugs, it can be estimated that more than $87 million was saved during the past year through increased generic substitution.

In addition to savings incurred through generic substitution, patients also pay lower copayments for generic drugs. These copayments have remained steady during the past five years while copayments for other brand drugs have increased. Highmark's average retail generic price is $14 less than the national average.

"One focus of the physician and hospital programs is clinical quality", said Linda Weiland, Highmark's vice president of provider performance and information management. "We work collaboratively with health care providers to ensure patients receive evidence-based care in accordance with nationally established guidelines."

The QualityBLUE hospital P4P program was started in 2002 with six hospitals and has expanded to 63 hospitals participating in the program today. About two-thirds of all primary care physicians in Highmark's physician network participate in the Qualit
'/>"/>

SOURCE Highmark Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Simbionix and AABIP Sign Collaboration Agreement
2. Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100.
3. Alere and AirStrip Technologies - a Powerful Collaboration Brings Innovative Remote Patient Monitoring to Obstetrical Care
4. OvaGene Oncology Joins The Gynecologic Oncology Group (GOG) Industry Collaboration Team to Advance Gynecologic Cancer Research
5. Cornerstone Therapeutics Announces Collaboration with The Cough Company
6. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
7. Accumetrics, Inc., Daiichi Sankyo, Inc. and Eli Lilly and Company Launch Strategic U.S. Collaboration
8. Serono Symposia International Foundation in Collaboration With ESHRE Announces Public Competition in Reproductive Medicine
9. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
10. IDRI and PATH Enter into Research Collaboration Agreement to Evaluate Novel Adjuvants to Enhance Pandemic Influenza Vaccines
11. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  New York College of Health Professions announces ... portfolio with U.S. Patent #8,996,098 donated by its Chairman ... a surgical instrument that allows surgeons to view and ... in the traditional format of a slide that is ... during surgery, thus providing the surgeon real time analysis ...
(Date:4/1/2015)... and MOUNTAIN VIEW, Calif. , ... BSX ) announces that it has signed ... venture-backed medical device company that develops, manufactures and ... guided transluminal drainage of targeted areas within the ... this week. The Xlumena portfolio ...
(Date:4/1/2015)... April 1, 2015  The first national study ... supplements to treat attention-deficit/hyperactivity disorder (ADHD) among children ... of children with ADHD were receiving behavioral therapy ... Control and Prevention (CDC) study, "Treatment of Attention-Deficit/Hyperactivity ... published today in The Journal of Pediatrics ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4
... YORK, Dec. 29, 2010 Reportlinker.com announces that a ... Regenerative Medicine Markets ... way of treating injured and diseased human tissue by ... As such, astounding new advancements in the ability to ...
... 2010 Reportlinker.com announces that a new market ... 2010-2015 In-depth Research Report on China ... Report SummaryBased on the ... General Administration of Custom, Ministry of Commerce , ...
Cached Medicine Technology:Reportlinker Adds Regenerative Medicine Markets 2Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry 2
(Date:4/1/2015)... South Florida’s newest concept in retirement living, Casa ... from the State of Florida. This approval is ... retirement community that will offer a catered lifestyle designed ... America’s aging population is experiencing unprecedented growth but is ... according to a recent report by Harvard’s Joint Center ...
(Date:4/1/2015)... April 01, 2015 IQ Formulations , ... and nutritional supplement companies in the U.S., today is commending ... and quality control standards for its herbal supplements.* GNC vowed ... chain to ensure the accuracy of labeling on its products. ... and IQ Formulations CEO Jay Cohen said: ...
(Date:4/1/2015)... Dr. Rod J. Rohrich , ... of the Department of Plastic Surgery at UT Southwestern ... reports of blindness resulting from the use of ... published their study, along with ideas for treatment and ... "We began to see increasing reports of blindness as ...
(Date:4/1/2015)... Senior Helpers of Central Texas ... of Choice Award by Home Care Pulse. The Best of ... to home care providers who receive the highest satisfaction scores ... in home care. This recognition reassures you that your home ... you with quality, trustworthy in home care. , In order ...
(Date:4/1/2015)... SkillSurvey, the leading provider of hiring ... and the premiere provider of on-line automated reference checking ... webinar on “Using Big Data to Recruit Millennials.” The ... officer of MorseLife, a nationally recognized provider of health ... families in Palm Beach County. , “As the most ...
Breaking Medicine News(10 mins):Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 3
... risk by 26%, study finds , , TUESDAY, Aug. 5 (HealthDay News) ... you smarter, as your grandmother said, but by lowering the risk ... a new study. , The benefit appears to come from fish ... tuna three times a week can reduce the risk of dementia ...
... May Need a Liver ... Transplant, SACRAMENTO, Calif., Aug. ... she heads to the Mrs.,America* competition in Tucson, Arizona on September 2, she ... Connor will be,healthy again. Connor was born with a deadly liver disease -- ...
... CINCINNATI, Aug. 5 The Procter & Gamble,Company (NYSE: ... the April -,June quarter to $21.3 billion and nine percent ... sales were up five percent for both,the quarter and the ... in which P&G delivered top-line growth at or above the,company,s ...
... Advice to Las Vegas, SCARBOROUGH, N.Y., Aug. 5 ... turning to Bald Girls Do Lunch(R) for cool options,and ... organization,is bringing women with alopecia areata together for the ... The August 15 Las Vegas event is a ...
... aims to give back to Mercy Ships , ... Garden Valley. TX ... of Britain,s greatest medal hopes at the Beijing Olympics, racer Paul Goodison, ... provides free medical care to the people of Africa. , , , ...
... QHR client hospital Gritman Medical Center and its ... Hospital, were recently ranked number one in a ... Services (CMS) in "overall patient satisfaction" in the ... to sharing number one rankings, the hospitals also ...
Cached Medicine News:Health News:Fish May Ward Off Dementia and Stroke 2Health News:Fish May Ward Off Dementia and Stroke 3Health News:Mrs. California Uses Her Title to Save Lives - She Now Heads to Mrs. America Competition 2Health News:Mrs. California Uses Her Title to Save Lives - She Now Heads to Mrs. America Competition 3Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 2Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 3Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 4Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 5Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 6Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 7Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 8Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 9Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 10Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 11Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 12Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 13Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 14Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 15Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 16Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 17Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 18Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 19Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 20Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 21Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 22Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 23Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 24Health News:Too Hot for Wigs: Bald Women Go Natural in Nevada 2Health News:Olympic Sailing Hopeful Backs Hospital Ship Charity 2Health News:Olympic Sailing Hopeful Backs Hospital Ship Charity 3Health News:Olympic Sailing Hopeful Backs Hospital Ship Charity 4Health News:Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital 2Health News:Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital 3
... an ELISA method for the qualitative detection of ... in human serum. When the EBNA IgG test ... as the EBV viral capsid IgG or IgM, ... the results can serve as an aid in ...
... VCA IgM Test is an ELISA method for ... Virus viral capsid antigen (VCA) in human serum. ... conjunction with other testing such as the EBV ... antigen tests and/or heterophile tests, the results can ...
... ImmunoDOT Borrelia (Lyme) test is ... test for the qualitative detection ... (anti-P39) and related Borrelia burgdorferi ... are detected in serum as ...
... Tests are qualitative enzyme immunoassays (EIA) for ... (IgG or IgM, respectively) in serum. Equivocal ... be supplemented with a standardized western blot ... to support a clinical diagnosis of B. ...
Medicine Products: